# Clinical Trial to Evaluate the Efficacy and the Tolerance of an Omega 3 Fatty Acids Supplementation in ADHD Children

> **NCT00770627** · PHASE4 · UNKNOWN · sponsor: **Laboratoires URGO** · enrollment: 160 (estimated)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **DIETARY_SUPPLEMENT:** Omega 3 caps

## Key facts

- **NCT ID:** NCT00770627
- **Lead sponsor:** Laboratoires URGO
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-10
- **Primary completion:** 2010-07
- **Final completion:** 2010-12
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2010-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00770627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00770627, "Clinical Trial to Evaluate the Efficacy and the Tolerance of an Omega 3 Fatty Acids Supplementation in ADHD Children". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00770627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*